Few developments have reshaped the fine jewellery conversation as rapidly and consequentially as the rise of lab-grown diamonds. In a decade, laboratory production has moved from a technical curiosity to a commercially significant market force, transforming consumer expectations around price and accessibility while simultaneously clarifying, for those paying attention, the precise nature of the premium that natural diamonds command.
Understanding what has happened — and what it means for the various segments of the jewellery market — requires disentangling several distinct conversations that tend to run together in popular coverage of the subject: the scientific reality of lab-grown diamonds, the market dynamics that their emergence has created, and the implications for collectors and investors in natural stones.
What Lab-Grown Diamonds Actually Are
The foundational point is worth stating precisely: lab-grown diamonds are chemically, physically, and optically identical to natural diamonds. They are not simulants — materials such as cubic zirconia or moissanite that resemble diamonds without sharing their composition — but genuine diamond crystals, composed of carbon in the same tetrahedral lattice structure, with the same hardness, thermal conductivity, and optical properties as their natural counterparts.
They are produced by two primary methods. Chemical Vapour Deposition (CVD) involves placing a diamond seed crystal in a chamber filled with carbon-rich gas; a plasma reaction causes carbon atoms to deposit onto the seed, growing a diamond layer by layer. High Pressure High Temperature (HPHT) replicates the conditions under which natural diamonds form in the earth, subjecting carbon to extreme pressure and temperature in the presence of a catalyst.
Neither process is instantaneous: growing a one-carat diamond takes days to weeks depending on the method and target quality. But the economics are transformative. The marginal cost of growing a one-carat diamond has declined precipitously as the technology has matured, and with it the retail price of lab-grown stones has fallen at a rate that surprised even the most pessimistic industry analysts.
The Price Collapse and Its Implications
In 2015, lab-grown diamonds retailed at roughly 15–20% below natural diamond prices. By 2020, the discount had widened to 40–60%. By 2023–2024, one-carat lab-grown diamonds of equivalent apparent quality were available at discounts of 80–90% relative to natural stones of the same grade. This price trajectory reflects the fundamental economics of manufactured goods: as production scales and technology improves, prices fall toward the marginal cost of production.
This collapse has had cascading effects across the diamond market. The middle of the natural diamond market — stones in the one-to-two-carat range in commercial and near-gem qualities — has faced the most direct competitive pressure. Consumers who previously might have purchased a one-carat natural diamond in the G-H colour, VS2-SI1 clarity range, and viewed that purchase as both an aesthetic acquisition and a store of value, now face a choice that the market had never previously offered: an identical-appearing stone at a fraction of the price.
The response from the natural diamond industry has been to accelerate a distinction it had previously underplayed: the emphasis on natural diamonds as the products of a geological process spanning billions of years, objects whose rarity is inherent and whose formation predates human existence. This narrative is accurate, but it represents a significant shift from the category’s historical marketing, which focused on aesthetic and romantic associations rather than explicitly on geological rarity as a differentiating value proposition.
Implications for the High-End Natural Diamond Market
The impact on natural diamonds has not been uniform across the market. At the lower end — commercial and near-gem quality stones in standard sizes — the pricing pressure from lab-grown competition has been substantial and is likely structural rather than temporary. The value proposition of a natural diamond in this tier has been fundamentally complicated by a competitor that appears identical and costs a fraction of the price.
At the upper end — stones above three carats in fine colour and clarity, fancy-coloured diamonds, and stones with notable provenance or auction history — the dynamics are quite different. Lab-grown production of large, fine-quality colourless diamonds is technically challenging and economically significant; producing a ten-carat D-IF lab-grown stone remains considerably more expensive than producing a one-carat equivalent. Fancy-coloured lab-grown diamonds present their own technical complexities. And crucially, the collectability of significant natural stones — their rarity, their individuality, and their potential as assets that appreciate over time — is an attribute that laboratory production cannot replicate, by definition.
The pink diamond market exemplifies this dynamic. Fine natural pink diamonds have continued to appreciate in value even as the lab-grown market has expanded, because the rarity of natural pink colour in large, fine-quality stones is absolute. A collector-grade five-carat natural Argyle pink diamond is not competing with anything that a CVD reactor can produce at comparable cost; its value derives from scarcity that is geological and therefore finite.
The Consumer Perspective: A Genuine Choice
For consumers who desire a beautiful diamond for personal adornment — an engagement ring, a significant gift, a piece of jewellery that will be worn and loved — the rise of lab-grown diamonds represents a genuinely positive development. The ability to acquire a visually exceptional stone at a dramatically reduced price, allowing a larger or finer-appearing stone than the same budget would have purchased in the natural market, is a real benefit.
The appropriate guidance for this buyer is transparency about what is being purchased. A lab-grown diamond is a beautiful object with real sentimental and aesthetic value; it should be chosen with clear understanding that it is not a store of value in the way that significant natural stones have historically been, and that its price trajectory suggests it will continue to decline in resale value rather than appreciate. Purchased as adornment with no investment expectation, it represents excellent value. Purchased as an investment or with expectations about resale recovery, it is likely to disappoint.
A Market Finding Its New Equilibrium
The fine jewellery market is in the process of finding a new equilibrium that accommodates both categories. Leading houses have made varied decisions about how to engage with lab-grown production, with some major brands launching explicit lab-grown lines while others have maintained a natural-stone-only position as a statement of differentiation. The most thoughtful industry voices argue that the categories should exist as distinct market segments rather than competitors — natural diamonds for collectors, investors, and buyers who value geological rarity; lab-grown for buyers who prioritise aesthetic quality and size at accessible price points.
This distinction, clearly maintained and clearly communicated, serves buyers in both segments. The confusion and controversy in the market have arisen primarily when the distinction has been blurred — when lab-grown stones have been sold without adequate disclosure, or when the natural diamond industry has overstated the case that lab-grown are fraudulent rather than different. In a market built on trust, clarity about what is being offered is the foundation on which all other value rests.
[ QUICK POLL // 60 SECONDS ]